The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia.
Journal for ImmunoTherapy of Cancer.
Times cited: 6
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
New England Journal of Medicine.
Times cited: 1805
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.
Journal of Clinical Oncology.
Times cited: 41